Rothmeier Andrea S, Marchese Patrizia, Langer Florian, Kamikubo Yuichi, Schaffner Florence, Cantor Joseph, Ginsberg Mark H, Ruggeri Zaverio M, Ruf Wolfram
From the Department of Immunology and Microbiology (A.S.R., F.S., W.R.) and Molecular Medicine (P.M., Y.K., Z.M.R.), The Scripps Research Institute, La Jolla, CA; II. Medical Clinic and Polyclinic, University Medical Center Eppendorf, Hamburg, Germany (F.L.); Department of Medicine, University of California San Diego, La Jolla (J.C., M.H.G.); Center for Thrombosis and Hemostasis, Johannes Gutenberg University Medical Center, Mainz, Germany (W.R.).
Arterioscler Thromb Vasc Biol. 2017 Jul;37(7):1323-1331. doi: 10.1161/ATVBAHA.117.309315. Epub 2017 May 11.
Coagulation initiation by tissue factor (TF) is regulated by cellular inhibitors, cell surface availability of procoagulant phosphatidylserine, and thiol-disulfide exchange. How these mechanisms contribute to keeping TF in a noncoagulant state and to generating prothrombotic TF remain incompletely understood.
Here, we study the activation of TF in primary macrophages by a combination of pharmacological, genetic, and biochemical approaches. We demonstrate that primed macrophages effectively control TF cell surface activity by receptor internalization. After cell injury, ATP signals through the purinergic receptor P2rx7 induce release of TF microvesicles. TF cell surface availability for release onto microvesicles is regulated by the GTPase arf6 associated with integrin α4β1. Furthermore, microvesicles proteome analysis identifies activation of Gα as a participating factor in the release of microvesicles with prothrombotic activity in flowing blood. ATP not only prevents TF and phosphatidylserine internalization but also induces TF conversion to a conformation with high affinity for its ligand, coagulation factor VII. Although inhibition of dynamin-dependent internalization also exposes outer membrane procoagulant phosphatidylserine, the resulting TF microvesicles distinctly lack protein disulfide isomerase and high affinity TF and fail to produce fibrin strands typical for microvesicles generated by thrombo-inflammatory P2rx7 activation.
These data show that procoagulant phospholipid exposure is not sufficient and that TF affinity maturation is required to generate prothrombotic microvesicles from a variety of cell types. These findings are significant for understanding TF-initiated thrombosis and should be considered in designing functional microvesicles-based diagnostic approaches.
组织因子(TF)引发的凝血过程受细胞抑制剂、促凝磷脂酰丝氨酸的细胞表面可用性以及硫醇-二硫键交换的调节。这些机制如何促使TF保持非凝血状态以及如何产生促血栓形成的TF尚不完全清楚。
在此,我们通过药理学、遗传学和生物化学方法相结合,研究原代巨噬细胞中TF的激活情况。我们证明,经预处理的巨噬细胞通过受体内化有效地控制TF的细胞表面活性。细胞损伤后,ATP通过嘌呤能受体P2rx7发出信号,诱导TF微泡释放。TF在微泡上释放的细胞表面可用性受与整合素α4β1相关的GTP酶arf6调节。此外,微泡蛋白质组分析确定Gα的激活是血液流动中具有促血栓形成活性的微泡释放的一个参与因素。ATP不仅阻止TF和磷脂酰丝氨酸内化,还诱导TF转变为对其配体凝血因子VII具有高亲和力的构象。尽管抑制依赖发动蛋白的内化也会暴露外膜促凝磷脂酰丝氨酸,但由此产生的TF微泡明显缺乏蛋白质二硫键异构酶和高亲和力TF,并且无法产生血栓炎症性P2rx7激活产生的微泡典型的纤维蛋白链。
这些数据表明,促凝磷脂暴露并不充分,从多种细胞类型产生促血栓形成的微泡需要TF亲和力成熟。这些发现对于理解TF引发的血栓形成具有重要意义,在设计基于功能性微泡的诊断方法时应予以考虑。